<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03494478</url>
  </required_header>
  <id_info>
    <org_study_id>6795</org_study_id>
    <nct_id>NCT03494478</nct_id>
  </id_info>
  <brief_title>Emotional Dysregulation in Adult ADHD.</brief_title>
  <acronym>EMO-TDA</acronym>
  <official_title>Emotional Dysregulation and Cyclothymia in Adult Patients With ADHD: Cohort Follow-up of Patients in Two Referral Centers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Attention deficit disorder in adults with or without hyperactivity (ADHD) is a common
      disorder, affecting around 3% of the population. ADHD increases the risk of psychiatric
      disorders (mood disorders, sleep disorders, personality disorders, addictive behavior), risky
      behaviors, and vocational difficulties. Emotional dysregulation (ED) constitute a major
      hindrance in the daily life of subjects, with a great impact on the general functioning and
      the quality of life of the patients.

      The investigators want to determine the characteristics of patients with each type of ED
      (impulsivity, exacerbated emotional intensity, cyclothymia, borderline personality traits),
      and study the stability of these traits over time. Since circadian rhythms influence mood and
      circadian rhythms frequently occur in patients with ADHD, the investigators want to determine
      if there is a link between ED and instability in circadian rhythms. Finally, they would like
      to observe whether the ED evolves and according to whether or not treatment is taken
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Score of cyclothymia (TEMPS-A scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)</measure>
    <time_frame>At 12 months after inclusion</time_frame>
    <description>Score of cyclothymia (TEMPS-A scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Score of emotional lability (ALS scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)</measure>
    <time_frame>At 12 months after inclusion</time_frame>
    <description>Score of emotional lability (ALS scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Score of emotional dysregulation (WRAADDS scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)</measure>
    <time_frame>At 12 months after inclusion</time_frame>
    <description>Score of emotional dysregulation (WRAADDS scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Score of borderline personality symptoms (BSL scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)</measure>
    <time_frame>At 12 months after inclusion</time_frame>
    <description>Score of borderline personality symptoms (BSL scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between emotional dysregulation, cognitive deficits and circadian instability</measure>
    <time_frame>At inclusion</time_frame>
    <description>Correlation between emotional dysregulation and executive and attentional dysfunction measured with the TAP test.
Correlation between emotional dysregulation and instability index of circadian rhythms measured by actimetry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between emotional dysregulation, cognitive deficits and circadian instability</measure>
    <time_frame>At 12 months after inclusion</time_frame>
    <description>Correlation between emotional dysregulation and executive and attentional dysfunction measured with the TAP test.
Correlation between emotional dysregulation and instability index of circadian rhythms measured by actimetry.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Adult ADHD</condition>
  <arm_group>
    <arm_group_label>Cohort group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will have evaluations at inclusion and 12 months. Neuropsychological testing Actimetry Selfquestionnaires on emotional topics</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological testing</intervention_name>
    <description>The assessment will will be done at the time of the initial evaluation (undiagnosed / untreated patients), then at one year of follow-up</description>
    <arm_group_label>Cohort group</arm_group_label>
    <other_name>attention</other_name>
    <other_name>working memory</other_name>
    <other_name>executive functions</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Actimetry</intervention_name>
    <description>The assessment will will be done at the time of the initial evaluation (undiagnosed / untreated patients), then at one year of follow-up.</description>
    <arm_group_label>Cohort group</arm_group_label>
    <other_name>Selfquestionnaires on emotional topics</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Self-questionnaires on emotional topics</intervention_name>
    <description>The assessment will will be done at the time of the initial evaluation (undiagnosed / untreated patients), then at one year of follow-up.</description>
    <arm_group_label>Cohort group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Male or female aged ≥ 18 years

          -  diagnosis of adult ADHD prior to inclusion

          -  Affiliated to a social health insurance

          -  Subject having dated and signed informed consent

          -  Subject having been informed of the results of the prior medical examination

        Exclusion criteria:

          -  Mobility project preventing follow-up for 1 year (planned move)

          -  impossibility to give the subject information enlightened (subject in emergency
             situation, difficulties in understanding the subject, mental retardation, illiteracy
             or insufficient command of the French language ...)

          -  Subject under the protection of justice

          -  Subject under guardianship or curatorship

          -  Pregnancy

          -  Breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sébastien WEIBEL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Madoé JULIANS, CRA</last_name>
    <phone>03 88 11 61 86</phone>
    <phone_ext>+33</phone_ext>
    <email>madoe.julians@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hélène SOAVELO, PC</last_name>
    <phone>03 88 11 65 59</phone>
    <phone_ext>+33</phone_ext>
    <email>helene.soavelo@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Spécialisé de Rouffach - Secteur 8</name>
      <address>
        <city>Rouffach</city>
        <zip>68250</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabrice DUVAL, MD</last_name>
      <phone>03 89 78 70 18</phone>
      <phone_ext>+33</phone_ext>
      <email>f.duval@ch-rouffach.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alexis ERB, MD</last_name>
      <phone>03 89 78 70 18</phone>
      <phone_ext>+33</phone_ext>
      <email>a.erb@ch-rouffach.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg - Service de Psyhciatrie 2/PPSAM</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sébastien WEIBEL, MD</last_name>
      <phone>03 88 11 51 57</phone>
      <phone_ext>+33</phone_ext>
      <email>sebastien.weibel@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Gilles BERTSCHY, MD</last_name>
      <phone>03 88 11 65 48</phone>
      <phone_ext>+33</phone_ext>
      <email>gilles.bertschy@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Charlotte KRAEMER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2018</study_first_posted>
  <last_update_submitted>May 17, 2018</last_update_submitted>
  <last_update_submitted_qc>May 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cohort study</keyword>
  <keyword>Emotion dysregulation</keyword>
  <keyword>Questionnaires</keyword>
  <keyword>Actimetry</keyword>
  <keyword>Neuropsychology</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

